Insider · CIK 0001185035
Timothy P Noyes
Files at JBIO (Aerovate Therapeutics, Inc.). First filing Nov 3, 2022, latest May 17, 2024.
In brief
Timothy P Noyes files SEC Form 4 as CEO and director at JBIO (Aerovate Therapeutics, Inc.). Since Nov 3, 2022, Timothy P Noyes has reported 0 open-market buys worth $0 and 7 open-market sells worth $1.3M, the latest filed on May 17, 2024.
A track record needs three past buys with six months of prices behind them; Timothy P Noyes has 0, so none is measured yet.
The newest scored trade: sold $216k of JBIO on May 16, 2024, filed May 17, 2024, scored 37 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
JBIO: Aerovate Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Aerovate Therapeutics, Inc. | $216k 10,000 shares | -100% | +129% from low-29% from high | |
| 38Weak | Aerovate Therapeutics, Inc. | $231k 11,357 shares | -114% | +118% from low-32% from high | |
| 38Weak | Aerovate Therapeutics, Inc. | $247k 10,000 shares | -100% | +147% from low-23% from high | |
| 39Weak | Aerovate Therapeutics, Inc. | $300k 10,000 shares | -100% | +221% from low0% from high | |
| 33Weak | Aerovate Therapeutics, Inc. | $11k 1,092 shares | -100% | +11% from low-65% from high | |
| 38Weak | Aerovate Therapeutics, Inc. | $270k 15,000 shares | -100% | +123% from low-29% from high | |
| 40Moderate | Aerovate Therapeutics, Inc. | $20k 1,038 shares | -100% | +135% from low-25% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 16, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 10,000 0.03% of outstanding | $216k | May 16, 2024 | $778k |
| May 1, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 11,357 0.04% of outstanding | $231k | May 1, 2024 | $547k |
| Apr 16, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 10,000 0.04% of outstanding | $247k | Apr 16, 2024 | $300k |
| Apr 1, 2024 | JBIO AEROVATE THERAPEUTICS, INC. | 10,000 0.04% of outstanding | $300k | Apr 1, 2024 | none |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 16, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $2.14 | $21k | 10,000 | May 17, 2024 |
| May 16, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,707 | $21.52 | $187k | 1,293 | May 17, 2024 |
| May 16, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,293 | $21.92 | $28k | 0 | May 17, 2024 |
| May 16, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 343,381 | May 17, 2024 |
| May 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $2.14 | $21k | 10,000 | May 3, 2024 |
| May 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,035 | $20.34 | $184k | 965 | May 3, 2024 |
| May 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -965 | $20.87 | $20k | 0 | May 3, 2024 |
| May 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,357 | $19.91 | $27k | 0 | May 3, 2024 |
| May 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 353,381 | May 3, 2024 |
| Apr 16, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $2.14 | $21k | 10,000 | Apr 18, 2024 |
| Apr 16, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,491 | $24.40 | $110k | 5,509 | Apr 18, 2024 |
| Apr 16, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,509 | $24.94 | $137k | 0 | Apr 18, 2024 |
| Apr 16, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 363,381 | Apr 18, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $2.14 | $21k | 10,000 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,502 | $28.96 | $130k | 5,498 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,647 | $29.90 | $49k | 3,851 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,851 | $31.02 | $88k | 1,000 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $31.95 | $32k | 0 | Apr 3, 2024 |
| Apr 1, 2024 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 373,381 | Apr 3, 2024 |
| Jan 29, 2024 | JBIO Aerovate Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jan 31, 2024 |
| Nov 1, 2023 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,092 | $10.42 | $11k | 0 | Nov 3, 2023 |
| Dec 1, 2022 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,000 | $2.14 | $32k | 15,000 | Dec 2, 2022 |
| Dec 1, 2022 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $18.00 | $270k | 0 | Dec 2, 2022 |
| Dec 1, 2022 | JBIO Aerovate Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 478,381 | Dec 2, 2022 |
| Nov 1, 2022 | JBIO Aerovate Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,038 | $19.50 | $20k | 0 | Nov 3, 2022 |
Questions about Timothy P Noyes
Answered from the filings on this page, as of the latest one.
Is Timothy P Noyes buying or selling?
Not in the last 12 months. Timothy P Noyes's latest open-market trade on SEC Form 4 was sold $216k of JBIO on May 16, 2024.
How did Timothy P Noyes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy P Noyes has 0.
Where does Timothy P Noyes file Form 4?
Timothy P Noyes has filed Form 4 at JBIO (Aerovate Therapeutics, Inc.) as CHIEF EXECUTIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.